Obesity drug sales help Novo Nordisk beat expectations
Shares in Danish pharma group down 40% since June amid questions over demand
Full Article
Obesity drug sales help Novo Nordisk beat expectations
FT.com
0 shares
1 views
You might like
Related news coverage
Novo Nordisk shares surge as Wegovy sales drive profit beat
Shares of Novo Nordisk climbed 4.5% on Wednesday after the Danish pharmaceutical giant reported a stronger-than-expected..
Invezz